Letter by Hoeper and Galiè Regarding Article, "hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients with Pulmonary Arterial Hypertension of Different Causes: Phase II Results from the Pulmonary Artery Denervation-1 Study"

Circulation: Cardiovascular Interventions

Volumn 9, Issue 1, 2016, Pages

  Hoeper, Marius M ^a   Galiè, Nazzareno ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR PROCEDURE; CAUSE OF DEATH; HUMAN; LETTER; LUNG FUNCTION; MORTALITY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PULMONARY ARTERY DENERVATION; PULMONARY HYPERTENSION; SURVIVAL; CONNECTIVE TISSUE DISEASES; DENERVATION; FEMALE; HYPERTENSION, PULMONARY; INNERVATION; MALE; PULMONARY ARTERY;

CONNECTIVE TISSUE DISEASES; DENERVATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PULMONARY ARTERY;

EID: 84955320181     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003422     Document Type: Letter

References (5)

1. Chen SL, Zhang H, Xie DJ, Zhang J, Zhou L, Rothman AMK, Stone GW. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 Study. Circ Cardiovasc Interv. 2015; 8: e002837. doi: 10.1161/CIRCINTERVENTIONS.115.002837.
2. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009; 30: 394-403. doi: 10.1093/eurheartj/ehp022.
3. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015; 46: 903-975. doi: 10.1183/13993003.01032-2015.
4. Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H, Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013; 168: 871-880. doi: 10.1016/j.ijcard.2012.10.026.
5. Dardi F, Manes A, Palazzini M, Bachetti C, Mazzanti G, Rinaldi A, Albini A, Gotti E, Monti E, Bacchi Reggiani ML, Galiè N. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights. Eur Respir J. 2015; 46: 414-421. doi: 10.1183/09031936.00209914.